Clinical Failures Mark End for Agennix, Phytopharm
By Nuala Moran
Tuesday, May 28, 2013
LONDON – Two of Europe's longest-standing public biotechs are leaving the stage following clinical trial failures, with Agennix AG going into liquidation and Phytopharm plc announcing a reverse merger.
Outside of the US
Part of Thomson Reuters
Note: our contact information has changed
In the U.S. and Canada: +1-800-336-4474
Outside the U.S.: +44-203-684-1796
Hours: Monday - Friday, 8:00am - 6:00 pm EST
© 2017 Thomson Reuters. Reproduction, reposting content is strictly prohibited.